Home › Trial NCT01853748
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
- Trial IDNCT01853748
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorDana-Farber Cancer Institute
- Enrollment512
- Start date2013-05
- ConditionsBreast Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.